FITC-Compatible Human CD19 Protein (CD1-HM119F)
$810.00 – $1,800.00
KACTUS Biosystems FITC-Compatible Human CD19 Protein (CD1-HM119F) (catalog No. CD1-HM119F) is expressed from HEK293 with His tag at the C-Terminus.It contains Pro20-Lys291.
- Details & Specifications
- References
- More Offers
| Catalog No. | CD1-HM119F | 
|---|---|
| Product Name | FITC-Compatible Human CD19 Protein (CD1-HM119F) | 
| Supplier Name | KACTUS Biosystems | 
| Brand Name | KACTUS Biosystems | 
| Synonyms | CD19; B4; CVID3; Leu-12; MGC12802 | 
| Species | Human | 
| Source | HEK293 | 
| Accession | P15391-1 | 
| Product Tag | C-His | 
| Biotinylated | no | 
| Exact Sequence | Pro20-Lys291 | 
| Molecular Weight | The protein has a predicted MW of 60.1 kDa. Due to glycosylation, the protein migrates to 68-72 kDa based on Tris-Bis PAGE result. | 
| Form | Liquid | 
| Formulation | Supplied as 0.22 μm filtered solution in PBS (pH 7.4). | 
| Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC | 
| Endotoxin | Less than 1 EU per μg by the LAL method. | 
| Shipping | Shipped with dry ice. | 
| Stability & Storage | Valid for 12 months from date of receipt when stored at -80°C.; Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. | 
| Note | Products will be shipped from the warehouse in Massachusetts. Promotion is running from time to time. Welcome to send a request for quote to message@sydlabs.com. | 
| Order Offline | Syd Labs, Inc. 4 Avenue E, Hopkinton, MA 01748 USA. Phone: 1-617-401-8149 Fax: 1-617-606-5019 Email: message@sydlabs.com | 
Description
CD1-HM119F: FITC-Compatible Human CD19 Protein (CD1-HM119F)
CD19 is a B-lineage-specific transmembrane glycoprotein, the expression of which is maintained on more than 95% B-cell malignancies. This strict lineage restriction makes CD19 an ideal target for immune therapies using chimeric antigen receptors (CARs). T cells engineered to express a chimeric antigen receptor (CAR) against CD19 have recently been FDA approved for the treatment of relapsed or refractory large B-cell lymphoma. Despite the success and curative potential of CD19 CAR T cells, several reports describing disease relapse due to antigen loss are now emerging.
Please remember our product information: FITC-Compatible Human CD19 Protein (CD1-HM119F) catalog number: CD1-HM119F KACTUS Biosystems
 
 





 
 